Co-Diagnostics is a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests. Joint venture CoSara initiated clinical studies in India for a tuberculosis test on its PCR platform.
Company Info
Upcoming Milestones & Key Dates
India TB test clinical results
Clinical Development Pipeline
Recent News
Co-Diagnostics has submitted a dual 510(k) premarket notification, with a concurrent CLIA waiver request, to the FDA for its Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test on the Co-Dx PCR Pro instrument.
Co-Diagnostics joint venture CoSara initiated clinical studies in India for a tuberculosis test on its PCR platform.
Leadership Team
Chief Executive Officer
Chief Scientific Officer
Chief Financial Officer
Careers & Job Openings